Aryl substituted imidazoquinolines

US7598382B2 · kind B2 · utility

Assignee

• COLEY PHARMACEUTICAL GMBH · DE

Inventors

• David S. Hays · Woodbury, US
• Tushar A. Kshirsagar · Woodbury, US
• Philip D. Heppner · Woodbury, US
• Bryon A. Merrill · River Falls, US
• Michael E. Danielson · Windom, US
• John F. Gerster · Woodbury, US
• Chad A. Haraldson · Apple Valley, US
• Sarah Johannessen · Maplewood, US
• Maureen A. Kavanagh · Stanchfield, US
• Kyle J. Lindstrom · Houlton, US
• Michael J. Rice · Oakdale, US
• David Squire · Houlton, US
• Sarah Strong · Louisville, US
• Joshua R. Wurst · North St. Paul, US

Key dates

• Filing date: Jan 13, 2006
• Grant date: Oct 6, 2009
• Expiry date: May 28, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Aryl substituted imidazoquinoline compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.